TWD 26.9
(0.94%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -147.86 Million TWD | -660.45% |
2022 | -19.44 Million TWD | 38.42% |
2021 | -31.57 Million TWD | 63.21% |
2020 | -85.82 Million TWD | -87.51% |
2019 | -45.77 Million TWD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q1 | -136.46 Million TWD | 7.71% |
2024 Q2 | -136.46 Million TWD | 2.45% |
2023 FY | -147.86 Million TWD | -660.45% |
2023 Q2 | -16.79 Million TWD | 16.43% |
2023 Q1 | -20.09 Million TWD | -3.35% |
2023 Q4 | -147.86 Million TWD | 2.19% |
2023 Q3 | -151.18 Million TWD | -800.13% |
2022 Q3 | -22.81 Million TWD | 0.0% |
2022 Q4 | -19.44 Million TWD | 14.77% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Bio Preventive Medicine Corp. | 31.8 Million TWD | 564.865% |
Genomics BioSci & Tech. Co.,Ltd. | 30.57 Million TWD | 583.58% |
Advagene Biopharma Co., Ltd. | -64.32 Million TWD | -129.892% |
Taiwan Bio Therapeutics Co., Ltd | 20.48 Million TWD | 821.911% |
NaviFUS Corp. | -123.12 Million TWD | -20.093% |
G&E Herbal Biotechnology Co., Ltd. | -134.25 Million TWD | -10.143% |
Sinew Pharma Inc. | -160.34 Million TWD | 7.781% |
Lin BioScience, Inc. | -3.21 Billion TWD | 95.405% |
TaiwanJ Pharmaceuticals Co., Ltd. | -57.65 Million TWD | -156.459% |
Lumosa Therapeutics Co., Ltd. | -412.63 Million TWD | 64.165% |
Anti-Microbial Savior BioteQ Co., Ltd | -77.04 Million TWD | -91.928% |
SYN-TECH Chem. & Pharm. Co., Ltd. | -264.16 Million TWD | 44.025% |
AP Biosciences Inc | -196.52 Million TWD | 24.759% |
Sunmax Biotechnology Co., Ltd. | -680.6 Million TWD | 78.274% |
RBC Bioscience Corporation | 422.18 Million TWD | 135.025% |
Syngen Biotech Co.,Ltd. | 314.87 Million TWD | 146.961% |
EirGenix Inc. | -4.58 Billion TWD | 96.777% |
Enimmune corporation | -314.15 Million TWD | 52.932% |
Lukas Biomedical Inc. | 50.75 Million TWD | 391.339% |
BRIM Biotechnology, Inc. | -944.4 Million TWD | 84.343% |
3D Global Biotech Inc. | -11.43 Million TWD | -1192.9% |
TaiMed Biologics Inc. | 499.84 Million TWD | 129.583% |
Mycenax Biotech Inc. | 207 Million TWD | 171.431% |
TCI GENE Inc. | -689.25 Million TWD | 78.546% |
SynCore Biotechnology Co.,Ltd | -262.58 Million TWD | 43.687% |
Oneness Biotech Co., Ltd. | -414.87 Million TWD | 64.358% |
Eusol Biotech Co.,Ltd. | -209.33 Million TWD | 29.364% |
Feng Chi Biotech Corp. | -19.81 Million TWD | -646.323% |
NeoCore Technology Co., Ltd. | -196.39 Million TWD | 24.709% |
TWi Biotechnology, Inc. | -143.86 Million TWD | -2.785% |
Neith Corporation | -150.31 Million TWD | 1.625% |
Sunny Pharmtech Inc. | 120.87 Million TWD | 222.336% |
VBI | -25.31 Million TWD | -484.093% |
Ever Supreme Bio Technology Co., Ltd | -330.54 Million TWD | 55.265% |
GeneReach Biotechnology Corp. | 40.26 Million TWD | 467.23% |
Shine-On BioMedical Co.,Ltd. | -101.48 Million TWD | -45.704% |
CHO Pharma, Inc. | -203.79 Million TWD | 27.441% |
Andros Pharmaceuticals Co.,Ltd | -241.89 Million TWD | 38.87% |
MegaPro Biomedical Co., Ltd | -118.93 Million TWD | -24.324% |
Visgeneer Inc. | 31.28 Million TWD | 572.667% |
Greenyn Biotechnology Co., Ltd | -337.37 Million TWD | 56.171% |
BioLASCO Taiwan Co., Ltd. | -84.76 Million TWD | -74.45% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 74.05 Million TWD | 299.685% |
Sagittarius Life Science Corp | -120.57 Million TWD | -22.642% |
BioGend Therapeutics Co., Ltd. | -317.41 Million TWD | 53.415% |
GlycoNex Incorporation | -148.56 Million TWD | 0.47% |
Medigen Biotechnology Corp. | 688.73 Million TWD | 121.47% |
Pharmosa Biopharm Inc. | -829.69 Million TWD | 82.178% |
PharmaEngine, Inc. | -860.8 Million TWD | 82.822% |
Intech Biopharm Corporation | 1.35 Billion TWD | 110.894% |
Taiwan Advance Bio-Pharmaceutical Inc. | 137.99 Million TWD | 207.155% |
BiOptic Inc. | 12.59 Million TWD | 1274.309% |
TaiGen Biopharmaceuticals Holdings Limited | -299.96 Million TWD | 50.705% |
Senhwa Biosciences, Inc. | -1.3 Billion TWD | 88.705% |
NatureWise Biotech & Medicals Corporation | -101.87 Million TWD | -45.155% |
OBI Pharma, Inc. | -398.22 Million TWD | 62.868% |
Savior Lifetec Corporation | -812.54 Million TWD | 81.802% |
Great Novel Therapeutics Biotech & Medicals | -165.17 Million TWD | 10.478% |
Level Biotechnology Inc. | -453.9 Million TWD | 67.423% |
Medigen Vaccine Biologics Corporation | 621.53 Million TWD | 123.791% |
Meribank Biotech Co., Ltd | -365.41 Million TWD | 59.534% |
Acepodia, Inc. | -6.02 Billion TWD | 97.544% |
Caliway Biopharmaceuticals Co., Ltd. | -3.4 Billion TWD | 95.653% |